STOCKHOLM, March 17, 2015 – Elekta (EKTA-B.ST) has today completed its acquisition of Polish distributor, RTA, as announced August 25, 2014 (http://www.elekta.com/pressreleases/916835/elekta-announces-intention-to -acquire-rta-a-leading-distributor-in-poland.html). This deal will allow Elekta to leverage RTA’s existing relationships in order to strengthen Elekta’s position in Poland’s private and public health care sectors. Ian Alexander, Executive Vice President of Elekta's Region Europe, Africa, Latin America and Middle East, says: “The radiation therapy market is growing steadily as both private and public care providers strive to meet the need to deliver improved treatments. Bringing RTA into the Elekta family is a natural progression that will help meet this need and will benefit Polish cancer centers and, ultimately, their patients. “Elekta’s strengthened position in Poland will also enable it to increase its presence in state-run and teaching hospitals,” he adds. As previously stated, the acquisition of RTA is expected to add 0.3 percent to Elekta’s revenues on an annual basis and is expected to be EPS accretive on an annual basis. With this finalization, RTA will change its name to Elekta and become a wholly -owned subsidiary. # # # For further information, please contact: Tobias Bülow, Director Financial Communication, Elekta AB Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com Time zone: CET: Central European Time Gert van Santen, Group Vice President Corporate Communications, Elekta AB Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com Time zone: CET: Central European Time The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on March 17, 2015. About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
Elekta expands in Poland through acquisition STOCKHOLM,
Top 10 Most Recent News Articles
Union Pacific Faces $98.8 Million Arbitration Tab
A Missed Schedule Promise Got Very Expensive Railroad labor disputes can look like paperwork until the bill lands with a thud. Union Pacific is facing an estimated $98.8 million arbitration payout after a Special Board of Adjustments found that the carrier failed to implement a negotiated scheduling benefit for locomotive engineers. That is not loose change, and it is the...
Continue Reading
Travel Awards Spotlight Luxury Hospitality's Reach
Hong Kong’s awards roll call reads less like a scorecard than a map of where premium travel wants its money and attention to go next. The 2026 World’s Travel & Hotel Awards, released November 20, cast a very wide net: heritage palaces, city hotels, beach retreats, airlines, cruise operators, tourism boards, restaurants, serviced apartments and a fair number of...
Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools
A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...
Continue Reading
Lara Kirchner's Surgical Leadership Earns Recognition
Surgical care gets judged in the quiet moments nobody puts on a plaque: a sterile instrument ready when it must be, a handoff done cleanly, a team that does not let a rushed schedule turn into a bad outcome. That is why Lara L. Kirchner's recognition as a Pinnacle Professional of the Year deserves a more serious look than the usual congratulatory confetti. Kirchner is...
Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis
A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...
Continue Reading
Nansha's Trade Pitch Has Numbers, but Questions Remain
A Chilean cherry spending 22 days at sea can tell an investor plenty about where Guangzhou's Nansha District wants to sit in Asia-Pacific commerce. Not glamorous, no. But trade infrastructure rarely is until volumes pile up, routes deepen, and somebody else finds they cannot easily replicate the network. Nansha is using the expected 33rd APEC Economic Leaders' Meeting in...
Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny
August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...
Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors
Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...
Continue Reading
Swim Readiness Depends on Skills, Not Birthdays Alone
A child popping up calmly after a brief dunk tells you more than a birthday ever will. That is the sensible center of Woody Alpern's guidance for families weighing whether a child belongs in the next swim level. The Atlanta swim school expert's point is refreshingly free of the usual parental race: advancement is earned through repeatable skills, comfort, and judgment in...
Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof
Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...
Continue ReadingTop 5 Most Recently Viewed Articles
Beyond Finance Secures Legal Win with Permanent Injunction
Legal Victory for Beyond Finance Against Former Executive In a significant legal development, Beyond Finance has successfully secured a permanent injunction against its former Chief Marketing Officer, Grant Eckert. This ruling was handed down by a Texas court, illustrating a firm stance by Beyond Finance in upholding its non-competition agreements. Details of the Case The...
Continue Reading
Analyzing the Decline in Serve Robotics Inc's Short Interest
Understanding Serve Robotics Inc's Short Interest Trends Serve Robotics Inc (NYSE: SERV) has recently reported a noticeable decline in its short interest, down by 6.79% from the previous report. As of the latest data, around 13.64 million shares have been sold short, representing 19.08% of all available shares for trading. Notably, it would take traders an average of 1.53...
Continue Reading
FAT Brands Stock Trend Analysis: 52-Week Low Challenges
FAT Brands Faces Market Challenges at 52-Week Low In recent trading activities, FAT Brands Inc., trading under the ticker FATBB, has encountered significant market challenges, recently dropping to a 52-week low of $4.13. This recent low is indicative of the difficulties the company is facing amidst a shifting economic environment. Market Dynamics Affecting FAT Brands...
Continue Reading
Kraig Labs Leads the Charge in Revolutionary Silk Fabrication
Kraig Labs: Pioneering Spider Silk Innovation In recent years, the realm of biotechnology has witnessed significant advancements, particularly in the production of specialized materials. Kraig Biocraft Laboratories, or Kraig Labs, stands at the forefront of this innovative field, redefining the future of spider silk. This biotechnology company has gained recognition for...
Continue Reading
The Safar Twins Unveil Stunning Short Film Resonance
The Safar Twins Unveil a Captivating New Short Film Written and directed by interdisciplinary artist Parsa Afsharjavan, Resonance is an upcoming cinematic gem that promises to captivate audiences worldwide. This 30-minute short film, inspired by the intricate themes of duality and identity, is set to premiere in 2025 and navigate the global festival circuit. Introducing...
Continue Reading